These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10442759)

  • 21. Botulinum toxin in the treatment of vocal fold nodules.
    Allen JE; Belafsky PC
    Curr Opin Otolaryngol Head Neck Surg; 2009 Dec; 17(6):427-30. PubMed ID: 19858719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.
    Kaderbay A; Righini CA; Castellanos PF; Atallah I
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Jun; 135(3):205-207. PubMed ID: 29661610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional electrical stimulation of laryngeal adductor muscle restores mobility of vocal fold and improves voice sounds in cats with unilateral laryngeal paralysis.
    Katada A; Nonaka S; Adachi M; Kunibe I; Arakawa T; Imada M; Hayashi T; Zealear DL; Harabuchi Y
    Neurosci Res; 2004 Oct; 50(2):153-9. PubMed ID: 15380322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin efficacy in the treatment of patients with spasmodic dysphonia].
    Svetel M; Vasić M; Tomić G; Stanković P; Stojanović M; Dragasević N; Dergenc R; Vukasinović M; Pekmezović T; Petrović I; Kostić V
    Vojnosanit Pregl; 2007 Oct; 64(10):671-5. PubMed ID: 18041568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Office-based laryngeal injection of botulinum toxin for paradoxical vocal fold motion in a child.
    Montojo J; González R; Hernández E; Zafra M; Plaza G
    Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):1161-3. PubMed ID: 26032616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management with botulinum toxin in 11 cases of laryngeal synkinesis.
    Lekue A; García-López I; Santiago S; Del Palacio A; Gavilán J
    Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2397-402. PubMed ID: 25911949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin therapy for abductor spasmodic dysphonia.
    Woodson G; Hochstetler H; Murry T
    J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin injection in laryngeal dyspnea.
    Woisard V; Liu X; Bes MC; Simonetta-Moreau M
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):909-917. PubMed ID: 27600559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeatedly successful closure of the larynx for the treatment of chronic aspiration with the use of botulinum toxin A.
    Pototschnig CA; Schneider I; Eckel HE; Thumfart WF
    Ann Otol Rhinol Laryngol; 1996 Jul; 105(7):521-4. PubMed ID: 8678427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral Vocal Fold Medialization: A Treatment for Abductor Spasmodic Dysphonia.
    Dewan K; Berke GS
    J Voice; 2019 Jan; 33(1):45-48. PubMed ID: 29132808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abductor paralysis after botox injection for adductor spasmodic dysphonia.
    Venkatesan NN; Johns MM; Hapner ER; DelGaudio JM
    Laryngoscope; 2010 Jun; 120(6):1177-80. PubMed ID: 20513036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-Office Laryngology Injections.
    Dion GR; Nielsen SW
    Otolaryngol Clin North Am; 2019 Jun; 52(3):521-536. PubMed ID: 30905566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia.
    Adler CH; Bansberg SF; Krein-Jones K; Hentz JG
    Mov Disord; 2004 Sep; 19(9):1075-9. PubMed ID: 15372600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
    Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
    J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
    Cha W; Jang JY; Wang SG; Kang JH; Jo MG
    J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cricothyroid onabotulinum toxin A injection to avert tracheostomy in bilateral vocal fold paralysis.
    Daniel SJ; Cardona I
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):867-9. PubMed ID: 25123108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unilateral vocal fold adductor paralysis after tracheal intubation.
    Goto T; Nito T; Ueha R; Yamauchi A; Sato T; Yamasoba T
    Auris Nasus Larynx; 2018 Feb; 45(1):178-181. PubMed ID: 28119095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review.
    Watts C; Nye C; Whurr R
    Clin Rehabil; 2006 Feb; 20(2):112-22. PubMed ID: 16541931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.